Medicaid Policy and Liver Transplant for Alcohol‐Associated Liver Disease
Brian P. Lee, Eric Vittinghoff, Mark J. Pletcher, Jennifer L. Dodge, Norah A. Terrault – 8 November 2019
Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate Endpoints
Naim Alkhouri, Rohit Kohli, Ariel E. Feldstein – 8 November 2019 – Nonalcoholic fatty liver disease (NAFLD) is common in children and may progress to nonalcoholic steatohepatitis (NASH), advanced fibrosis, and even cirrhosis in childhood or early adulthood, indicating the need for pharmacologic treatment in this age group. Multiple trials are evaluating different therapeutic targets for NASH with fibrosis in adults, and the U.S.
Studying the Exposome to Understand the Environmental Determinants of Complex Liver Diseases
Angela C. Cheung, Douglas I. Walker, Brian D. Juran, Gary W. Miller, Konstantinos N. Lazaridis – 8 November 2019
Pre–Liver Transplant Cardiac Catheterization Is Associated With Low Rate of Myocardial Infarction and Cardiac Mortality
Issa Kutkut, Rayan Jo Rachwan, Lava R. Timsina, Marwan S. Ghabril, Marco A. Lacerda, Chandrashekhar A. Kubal, Patrick D. Bourdillon, Richard S. Mangus – 7 November 2019
A Cautionary Report of Doxycycline‐Induced Autoimmune Hepatitis
Ali Fakhreddine, Catherine Frenette – 7 November 2019
A Cautionary Report of Doxycycline‐Induced Autoimmune Hepatitis
Ali Fakhreddine, Catherine Frenette – 7 November 2019
γδT Cells and CD1d, Novel Immune Players in Alcoholic and Nonalcoholic Steatohepatitis?
Xiaolin Wang, Bin Gao – 7 November 2019
Pregenomic HBV RNA and Hepatitis B Core‐Related Antigen Predict Outcomes in Hepatitis B e Antigen–Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy
Ivana Carey, Jeffrey Gersch, Bo Wang, Christiana Moigboi, Mary Kuhns, Gavin Cloherty, Geoffrey Dusheiko, Kosh Agarwal – 7 November 2019
Stathmin 1 Induces Murine Hepatocyte Proliferation and Increased Liver Mass
Enpeng Zhao, Yang Shen, Muhammad Amir, Alton B. Farris, Mark J. Czaja – 7 November 2019 – The endogenous cellular signals that initiate the transition of hepatocytes from quiescence to proliferation remain unclear. The protein stathmin 1 (STMN1) is highly expressed in dividing cells, including hepatocytes, and functions to promote cell mitosis through physical interactions with tubulin and microtubules that regulate mitotic spindle formation.
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response‐Based Approach
Guohong Han, Sarah Berhane, Hidenori Toyoda, Dominik Bettinger, Omar Elshaarawy, Anthony W. H. Chan, Martha Kirstein, Cristina Mosconi, Florian Hucke, Daniel Palmer, David J. Pinato, Rohini Sharma, Diego Ottaviani, Jeong W. Jang, Tim A. Labeur, Otto M. Delden, Mario Pirisi, Nick Stern, Bruno Sangro, Tim Meyer, Waleed Fateen, Marta García‐Fiñana, Asmaa Gomaa, Imam Waked, Eman Rewisha, Guru P. Aithal, Simon Travis, Masatoshi Kudo, Alessandro Cucchetti, Markus Peck‐Radosavljevic, R.B. Takkenberg, Stephen L. Chan, Arndt Vogel, Philip J. Johnson – 7 November 2019